Which has the lower trailing P/E, ETON or OMCL?

OMCL has the lower trailing P/E: ETON trades at 141.91 and OMCL at 41.72. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ETON or OMCL?

Over the past five years, ETON grew revenue faster — ETON at a 47.98% CAGR versus OMCL at 4.77%.

Is ETON or OMCL more profitable?

ETON runs the higher net margin — ETON at 12.02% versus OMCL at 3.13%.

How have ETON and OMCL total returns compared?

Over the past 5 years, ETON delivered 63.04% and OMCL delivered -26.44% annualized total return. Past performance doesn't predict future results.

Eton Pharmaceuticals, Inc. (ETON) vs Omnicell, Inc. (OMCL)

A side-by-side comparison of Eton Pharmaceuticals, Inc. and Omnicell, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ETON

Eton Pharmaceuticals, Inc.

$1.49B

$54.58HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT

OMCL

Omnicell, Inc.

$1.60B

$35.25HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT

Total return — ETON vs OMCL

growth of $100 · dividends reinvested · last 8y

ETON +789.9% (+31.4%/yr)OMCL -52.8% (-9.0%/yr)ETON compounded faster over this window

Log scale — wide-divergence pair

ETON OMCL

ETON vs OMCL: by the numbers

•OMCL is the larger company ($1.60B vs $1.49B market cap).
•OMCL trades at the lower trailing earnings multiple (41.72 vs 141.91 P/E), one valuation lens rather than an overall verdict.
•ETON converts more revenue to profit (12.02% vs 3.13% net margin).
•ETON grew revenue faster over the past five years (47.98% vs 4.77% CAGR).

Metrics side by side

Valuation

Metric	ETON	OMCL
P/E ratio	141.91	41.72
Forward P/E	50.19	15.54
P/S ratio	14.16	1.29
P/B ratio	32.09	1.24
EV / EBITDA	71.80	10.68
FCF yield	0.98%	8.82%

Profitability

Metric	ETON	OMCL
Gross margin	57.87%	44.77%
Operating margin	0.09%	4.73%
Net margin	12.02%	3.13%
ROE	27.24%	3.03%
ROIC	20.41%	2.43%

Growth (annualized)

Metric	ETON	OMCL
Revenue CAGR (5Y)	47.98%	4.77%
EPS CAGR (5Y)	N/A	-43.29%
FCF CAGR (5Y)	N/A	-8.10%
Total return CAGR (5Y)	63.04%	-26.44%

Frequently asked

Which has the lower trailing P/E, ETON or OMCL?: OMCL has the lower trailing P/E: ETON trades at 141.91 and OMCL at 41.72. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ETON or OMCL?: Over the past five years, ETON grew revenue faster — ETON at a 47.98% CAGR versus OMCL at 4.77%.
Is ETON or OMCL more profitable?: ETON runs the higher net margin — ETON at 12.02% versus OMCL at 3.13%.
How have ETON and OMCL total returns compared?: Over the past 5 years, ETON delivered 63.04% and OMCL delivered -26.44% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ETON analysis Full OMCL analysis Interactive comparison tool

Dig into the metrics

Eton Pharmaceuticals P/E ratio Omnicell P/E ratio Eton Pharmaceuticals ROE Omnicell ROE Eton Pharmaceuticals operating margin Omnicell operating margin Eton Pharmaceuticals revenue growth Omnicell revenue growth Eton Pharmaceuticals free cash flow Omnicell free cash flow

Eton Pharmaceuticals & Omnicell appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.